Article Information
vol. 10 no. 435
- Received for publication July 26, 2017
- Resubmitted September 28, 2017
- Accepted for publication March 23, 2018
- .
Author Information
- Amir H. Kashani1,*,
- Jane S. Lebkowski2,
- Firas M. Rahhal3,
- Robert L. Avery4,
- Hani Salehi-Had5,
- Wei Dang6,
- Chih-Min Lin6,
- Debbie Mitra1,
- Danhong Zhu7,
- Biju B. Thomas1,
- Sherry T. Hikita8,
- Britney O. Pennington8,
- Lincoln V. Johnson2,8,
- Dennis O. Clegg8,
- David R. Hinton1,7 and
- Mark S. Humayun1,9,*
- 1University of Southern California (USC) Roski Eye Institute, USC Institute for Biomedical Therapeutics, and Department of Ophthalmology, Keck School of Medicine, USC, 1450 San Pablo, Los Angeles, CA 90033, USA.
- 2Regenerative Patch Technologies, 150 Gabarda Way, Portola Valley, CA 94028–7445, USA.
- 3Retina Vitreous Associates Medical Group, 9001 Wilshire Boulevard, Suite 301, Beverly Hills, CA 90211, USA.
- 4California Retina Consultants, 525 East Micheltorena Street, Santa Barbara, CA 93103, USA.
- 5Atlantis Eyecare, 7777 Edinger Avenue, Suite 234, Huntington Beach, CA 92647, USA.
- 6Center for Biomedicine and Genetics, Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA.
- 7Department of Pathology, Keck School of Medicine, USC, 1441 Eastlake Avenue, NRT 7503, Los Angeles, CA 90033, USA.
- 8Center for Stem Cell Biology and Engineering, Neuroscience Research Institute, Mail Code 5060, University of California, Santa Barbara, CA 93016, USA.
- 9Department of Biomedical Engineering, 1042 Downey Way, Denney Research Center (DRB) 140, USC, Los Angeles, CA 90089–1111, USA.
- ↵*Corresponding author. Email: humayun{at}usc.edu (M.S.H.); ahkashan{at}usc.edu (A.H.K.)